EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Determination of arbutin in vitro and in vivo by LC-MS/MS: Pre-clinical evaluation of natural product arbutin for its early medicinal properties

Qiao-Lai Wang, Pei-Xi Zhang, Rui Shen, Meng Xu, Liang Han, Xuan Shi, Zi-Rui Zhou, Jing-Yi Yang, Jie-Qing Liu

Journal of Ethnopharmacology · 2024

DOI: 10.1016/j.jep.2024.118232 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Ethnopharmacology, 2024. Verfasst von Qiao-Lai Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Huaqiao University, 269 Chenghua North Road, Fengze District, Quanzhou, 362021, China. Electronic address: 1515406531@qq.com. Hauptthemen laut MEDLINE: Arbutin, Tandem Mass Spectrometry, Rats, Sprague-Dawley. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ETHNOPHARMACOLOGICAL RELEVANCE: Arbutin is a naturally occurring glucoside extracted from plants, known for its antioxidant and tyrosinase inhibiting properties. It is widely used in cosmetic and pharmaceutical industries. With in-depth study of arbutin, its application in disease treatment is expanding, presenting promising development prospects. However, reports on the metabolic stability, plasma protein binding rate, and pharmacokinetic properties of arbutin are scarce. AIM OF THE STUDY: The aim of this study is to enrich the data of metabolic stability and pharmacokinetics of arbutin through the early pre-clinical evaluation, thereby providing some experimental basis for advancing arbutin into clinical research. MATERIALS AND METHODS: We developed an efficient and rapid liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay for determining arbutin in plasma. We investigated the metabolic and pharmacokinetic properties of arbutin through in vitro metabolism assay, cytochrome enzymes P450 (CYP450) inhibition studies, plasma protein binding rate analysis, Caco-2 cell permeability tests, and rat pharmacokinetics to understand its in vivo performance. RESULTS: In vitro studies show that arbutin is stable, albeit with some species differences. It exhibits low plasma protein binding (35.35 ± 11.03% ∼ 40.25 ± 2.47%), low lipophilicity, low permeability, short half-life (0.42 ± 0.30 h) and high oral bioavailability (65 ± 11.6%). Arbutin is primarily found in the liver and kidneys and is eliminated in the urine. It does not significantly inhibit CYP450 up to 10 μM, suggesting a low potential for drug interactions. Futhermore, preliminary toxicological experiments indicate arbutin's safety, supporting its potential as a therapeutic agent. CONCLUSION: This study provides a comprehensive analysis the drug metabolism and pharmacokinetics (DMPK) of arbutin, enriching our understanding of its metabolism stability and pharmacokinetics properties, It establishes a foundation for further structural optimization, pharmacological studies, and the clinical development of arbutin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArbutinTandem Mass SpectrometryRats, Sprague-DawleyAnimalsHumansCaco-2 CellsMaleChromatography, LiquidRatsMicrosomes, LiverProtein BindingCytochrome P-450 Enzyme SystemBiological ProductsCytochrome P-450 Enzyme InhibitorsLiquid Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

ArbutinCYP450 inhibitionCaco-2 cell modelMetabolism stabilityPharmacokineticsPlasma protein binding rate

Substanzen

ArbutinCytochrome P-450 Enzyme SystemBiological ProductsCytochrome P-450 Enzyme Inhibitors

Autor:innen und Institutionen

  • School of Medicine, Huaqiao University, 269 Chenghua North Road, Fengze District, Quanzhou, 362021, China. Electronic address: 1515406531@qq.com.
  • School of Medicine, Huaqiao University, 269 Chenghua North Road, Fengze District, Quanzhou, 362021, China.
  • Sheng Xia Innovation Pharmaceutical Technology Co., Ltd., Xiamen, 361000, China.
  • School of Medicine, Huaqiao University, 269 Chenghua North Road, Fengze District, Quanzhou, 362021, China; Engineering Research Centre of Molecular Medicine of Ministry of Education, Key Laboratory of Fujian Molecular M…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, Q. L., Zhang, P. X., Shen, R., Xu, M., Han, L., Shi, X., Zhou, Z. R., Yang, J. Y., & Liu, J. Q. (2024). Determination of arbutin in vitro and in vivo by LC-MS/MS: Pre-clinical evaluation of natural product arbutin for its early medicinal properties. Journal of Ethnopharmacology. https://doi.org/10.1016/j.jep.2024.118232

Vancouver

Wang QL, Zhang PX, Shen R, Xu M, Han L, Shi X, et al. Determination of arbutin in vitro and in vivo by LC-MS/MS: Pre-clinical evaluation of natural product arbutin for its early medicinal properties. Journal of Ethnopharmacology. 2024. doi:10.1016/j.jep.2024.118232

BibTeX
@article{Wang2024,
  author = {Wang, Qiao-Lai and Zhang, Pei-Xi and Shen, Rui and Xu, Meng and Han, Liang and Shi, Xuan and Zhou, Zi-Rui and Yang, Jing-Yi and Liu, Jie-Qing},
  title = {Determination of arbutin in vitro and in vivo by LC-MS/MS: Pre-clinical evaluation of natural product arbutin for its early medicinal properties},
  journal = {Journal of Ethnopharmacology},
  year = {2024},
  doi = {10.1016/j.jep.2024.118232}
}
Kostenlos starten →